================================================================================
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 3, 2004
CAS MEDICAL SYSTEMS, INC.
(Exact name of Registrant as specified in its charter)
Delaware 0-13839 06-1123096
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
44 East Industrial Road, Branford, Connecticut 06405
(Address of principal executive offices, including zip code)
(203) 488-6056
(Registrant's telephone number, including area code)
================================================================================
Item 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) Exhibits - The following exhibit is furnished as part of this report:
99.1 Press Release dated August 2, 2004.
Item 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On August 2, 2004, CAS Medical Systems, Inc. (the "Company") issued
the press release attached hereto as Exhibit 99.1 announcing the
results of operations and financial condition for the three months
ended June 30, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CAS MEDICAL SYSTEMS, INC.
Date: August 3, 2004 By: /s/ Jeffery A. Baird
--------------------------------
Jeffery A. Baird
Chief Financial Officer and
Principal Accounting Officer